比亞迪口罩位列2020年日本口罩銷量排行榜榜首
比亞迪電子(00285.HK)指,日經新聞公布「日經POS情報.受歡迎商品排名」排行榜,其中比亞迪平面口罩在2020年日本口罩銷量排行榜中位列榜首,成為首個在「口罩大國」日本獲得平面口罩銷冠的中國品牌。
比亞迪表示,疫情下公司3天設計出設備圖紙,7天完成口罩機的研發製造,迅速發動10萬員工,在50萬平方米的潔淨廠房裡建成2,000條口罩生產線,最大日產量達1億個口罩,建成熔噴布生產線192條,最大日產量達175噸,成為全球最大的口罩生產商。
截至目前,比亞迪生產的口罩已為80多個國家及地區提供保障,公司指,期望在後疫情時代將依託專業的裝備研發和生產製造團隊穩固佔據市場份額。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.